A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.
Indian J Dermatol, 2021 Objectives: To evaluate and compare the efficacy of MMR vaccine and MIP vaccine for resolution of Cutaneous warts (Cw). Methods: The hospital-based prospective randomized interventional study was done where a total of 60 patients of Cw were divided into ...
Kaur A +5 more
europepmc +2 more sources
Human Vaccines & Immunotherapeutics, 2017 This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine ...
Ashwani Sood +10 more
doaj +2 more sources
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination [PDF]
Human Vaccines & ImmunotherapeuticsThis study compared the immunogenicity of the measles-mumps-rubella (MMR) vaccine when administered alone versus when co-administered with the rotavirus vaccine in infants aged 8–9 months.
Xue-Feng Liang +3 more
doaj +2 more sources
Evaluation of knowledge, attitudes and vaccine hesitancy towards MMR vaccine among parents in the United Arab Emirates. [PDF]
PLoS ONEBackgroundThe Measles, Mumps, and Rubella (MMR) vaccine is highly effective, but vaccine hesitancy (VH) is a key barrier to achieving herd immunity. This study aims to assess the general attitudes and knowledge of UAE parents regarding measles and the ...
Kamel A Samara +5 more
doaj +2 more sources
Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers [PDF]
VirusesThe purpose of this study was to evaluate the effectiveness and immunogenicity of the measles–mumps–rubella (MMR) vaccine against SARS-CoV-2 in healthcare workers at one medical institution.
Hyeri Seok +9 more
doaj +2 more sources
medRxiv, 2021 Background: COVID-19 is still a challenge, both with regard to its treatment and to the actual efficacy of the vaccines available to date, especially with the emergence of new variants. We evaluated the efficacy of the measles-mumps-rubella (MMR) vaccine
Fedrizzi EN +25 more
europepmc +2 more sources
MMR Vaccine Adverse Drug Reactions Reports in the CDC WONDER System, 1989-2019. [PDF]
Open Forum Infect Dis, 2020 Introduction: From January 1 to June 20, 2019, 1,077 individual cases of measles have been confirmed in 28 states. This is the greatest number of cases reported in the U.S. since measles was declared eliminated in 2000.
Rodriguez-Nava G +6 more
europepmc +2 more sources
MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure? [PDF]
Indian Pediatr, 2020 MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure? 65% sequence identity and viral homologs are detected in numerous coronaviruses, concluding that the observed homology is similar to an anamnestic reaction to SARS-CoV-2 by ...
Deshpande S, Balaji S.
europepmc +2 more sources
A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration. [PDF]
Case Rep Dermatol Med, 2023 Nazir HI, Hess AA, Soni A, Potter KA.
europepmc +3 more sources
Knowledge, attitudes and opinions towards measles and the MMR vaccine across two NSW cohorts
Australian and New Zealand Journal of Public Health, 2017 Objective: Although the number of national measles cases has greatly decreased since 1980s, there has been resurgence in disease incidence in recent years. While parental knowledge and attitudes toward both disease and vaccinations are known to influence
Daniel Brieger +3 more
doaj +2 more sources